Metastatic MiT family/TFE translocation renal cell carcinoma in adults: case series reports and literature reviews

This article presents a case study of three patients diagnosed with MiT/TFE tRCC at our hospital. The tumors were located in the left kidney of all three patients, with two of them being under 30 years old. Within a short timeframe, two of all patients developed liver metastases. Genetic testing was conducted in one case, FISH testing in another, and all cases underwent a combination of targeted therapy and immunotherapy. By analyzing the clinical, pathological, and genomic characteristics of these patients, this article aims to enhance the understanding of MiT family translocation renal cell carcinoma, as well as improve the diagnosis, treatment, and prognosis of this rare form of renal cell carcinoma. Further evidence is provided to support these findings.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2025-03-19
DOI
https://doi.org/10.3389/fonc.2025.1501820
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metastatic MiT family/TFE translocation renal cell carcinoma in adults: case series reports and literature reviews

Xiaofeng Cong, Xiuyue Man, Hong Wang, Chen Chen et al.
Frontiers in Oncology
Renal cell carcinoma treatment
article

Metastatic MiT family/TFE translocation renal cell carcinoma in adults: case series reports and literature reviews

Xiaofeng Cong, Xiuyue Man, Hong Wang, Chen Chen, Lei Yang, Jing Zhang, Xueru Sun
article en

Abstract

This article presents a case study of three patients diagnosed with MiT/TFE tRCC at our hospital. The tumors were located in the left kidney of all three patients, with two of them being under 30 years old. Within a short timeframe, two of all patients developed liver metastases. Genetic testing was conducted in one case, FISH testing in another, and all cases underwent a combination of targeted therapy and immunotherapy. By analyzing the clinical, pathological, and genomic characteristics of these patients, this article aims to enhance the understanding of MiT family translocation renal cell carcinoma, as well as improve the diagnosis, treatment, and prognosis of this rare form of renal cell carcinoma. Further evidence is provided to support these findings.

Frontiers in OncologyVol. 15
Jilin University (CN), First Hospital of Jilin University (CN)
Good health and well-being
Openalex Percentile: Top 92%
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.